Page 76 - Winter2020

Clinical nal whole-cell DTP vaccines call into question localized and systemic—which include anaphy-

trial results how much safer the acellular DTaP and Tdap laxis, urticaria (hives), Guillain-Barré syndrome
vaccines are when given to children and adults. (GBS), insulin-dependent diabetes mellitus,
and post- According to Fisher, NVIC continues to receive idiopathic thrombocytopenic purpura (ITP),
marketing reports of serious reactions and injuries from myelitis and sudden infant death syndrome
36
data listed today’s acellular versions—reactions consis- (SIDS), among many others (see Table 1).
tent with those reported following receipt of
Fisher’s 1985 book details more than one
in vaccine whole-cell vaccines—including high-pitched hundred cases of brain inflammation and im-
inserts reveal screaming, fever over 103 degrees F, collapse mune system dysfunction induced by whole-cell
34
a wide variety or shock, convulsions and brain inflammation. DPT vaccination, including in children who
Although studies have reported that DTaP developed regressive autism after suffering
of possible and Tdap vaccines are far less reactive than post-vaccination encephalopathy. Of note, the
3
acute and whole-cell vaccines, acellular vaccines contain CDC and other government entities continue
chronic DTaP chemically inactivated pertussis toxin (ten to to deny any link between vaccines and autism,
twenty-five micrograms per dose), which still even though federal compensation has been
and Tdap retain varying levels of bioactivity. This may quietly awarded to children who developed brain
35
reactions. induce brain inflammation in some individuals, inflammation after both the old and new DTP
although it is thought to occur less often than vaccines, whose permanent disabilities include
brain inflammation induced by the old whole- autistic behaviors. 37,38
cell pertussis vaccine. In addition, clinical trial Using the MedAlerts search engine, NVIC
results and post-marketing data listed in vaccine found that as of March 31, 2020, the Vaccine
inserts reveal a wide variety of possible acute Adverse Event Reporting System (VAERS) had
and chronic DTaP and Tdap reactions—both received nearly one hundred ninety thousand

TABLE 1. Adverse Reactions Reported in DTaP and Tdap Vaccine Inserts

Abscess Erythema Myocarditis
Allergic reactions, anaphylaxis Extremity pain Myositis
Angioedema Facial palsy/paralysis Nervousness, restlessness
Anorexia Fever Neuritis, nerve compression
Apnea Fretfulness, fussiness, irritability Neutropenia
Arthralgia Gastroenteritis Pallor
Aspiration Headache, migraine Paresthesia
Asthenia Henoch-Schönlein purpura Pertussis
Asthma, bronchospasm Hypernatremia Petechiae
Back pain Hypoesthesia Pneumonia
Bronchitis, bronchiolitis Hypotonia Pruritus
Bulging fontanelle Hypotonic-hyporesponsive episode Rash
Cellulitis Hypoxia Respiratory tract/viral infection
Cerebrovascular accident Inconsolable/persistent crying Rhinitis
Constipation Increased arm or thigh circumference Screaming
Cough Infantile spasms Seizures, convulsions
Cyanosis Insomnia Sepsis
Death Invasive Hib disease Shortness of breath
Dehydration Loss of appetite Sudden infant death syndrome
Diabetes mellitus (insulin-dependent) Lymphadenopathy Swelling
Diarrhea, nausea, vomiting Malaise Syncope
Drowsiness, lethargy, somnolence Meningitis Thrombocytopenic purpura
Earache Muscle weakness, pain Unresponsiveness
Encephalitis, encephalopathy Myelitis Urticaria

SOURCE: https://childrenshealthdefense.org/news/read-the-fine-print-part-
two-nearly-400-adverse-reactions-listed-in-vaccine-package-inserts/
74 Wise Traditions WINTER 2020